Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Strides Pharma Science Ltd.

www.strides.com

Latest From Strides Pharma Science Ltd.

More Top-Level Pharma Changes In India, Cipla Gets CSO

Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.

India Commercial

Strides Acquires 18 ANDAs From Pharmaceutics

Strides has acquired 18 ANDAs from Pharmaceutics International, as well as exclusive marketing rights to a levothyroxine sodium candidate. Through this agreement, the Indian company plans to expand its niche offerings.

Deals Generic Drugs

New Strides CEO Puts Emphasis On Execution

Strides' newly-appointed CEO, R Ananthanarayanan, sees no reason to change course as the firm's current strategy continues to yield positive results. The company posted a 29% increase in third-quarter revenues on the back of 62% growth in the US.

Strategy Sales & Earnings

Strides' New CEO Reiterates Strategy, Thrust On Execution

Newly-appointed CEO at Strides, R Ananthanarayanan, sees no reason to change course as current strategy continues yielding positive results. Company posts 29% increase in third-quarter revenues on the back of 62% growth in the US

Commercial Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Strides Arcolab Ltd.
  • Strides Shasun Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Strides Pharma Science Ltd.
  • Senior Management
  • Shashank Sinha, Group CEO
    Badree Komandur, Group CFO
  • Contact Info
  • Strides Pharma Science Ltd.
    Phone: (91) 80 6784 0000
    Strides House, Bilekahalli
    Bannerghatta Rd
    Bangalore, 560076
    India
UsernamePublicRestriction

Register